AHL Partners LLP - ACORDA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
AHL Partners LLP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2015$1,168,000
+275.6%
27,314
+132.6%
0.09%
+83.7%
Q3 2015$311,000
-92.4%
11,743
-90.4%
0.05%
-69.8%
Q2 2015$4,076,000
-7.3%
122,275
-7.4%
0.16%
-8.0%
Q1 2015$4,396,000
+125.3%
132,101
+176.7%
0.18%
+74.3%
Q4 2014$1,951,00047,7420.10%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders